Sathananthan, Airani
3 papers on CoChat
Most cited papers
- Verified
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Del Prato, S., Kahn, S. E., Pavo, I., Weerakkody, G. J., Yang, Z., Doupis, J., Aizenberg, D., Wynne, A. G., Riesmeyer, J. S., Heine, R. J., et al. (2021) · The Lancet
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 684
- Verified
A model of GLP-1 action on insulin secretion in nondiabetic subjects
Dalla Man, C., Micheletto, F., Sathananthan, A., Rizza, R. A., Vella, A., & Cobelli, C. (2010) · American Journal of Physiology-Endocrinology and Metabolism
Pancreatic function and diabetesDiabetes Treatment and Management
Cited by 45
- Verified
Can Sorafenib Cause Hypothyroidism?
Robinson, S. I., Hobday, T. J., Sathananthan, A., Morris, J. C., & Mcwilliams, R. R. (2007) · Journal of Chemotherapy
Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free